Moberg Pharma is a Swedish specialty pharma company primarily focusing on dermatology products in the OTC segment, with strong market positions in selected niche segments. In addition, Moberg Pharma has two clinical projects. Moberg Pharma has its own sales and marketing organisation in the US and relies on a handful of distribution partners in the other regions. Moberg Pharma has expanded its product offering through a number of acquisitions.
We note a number of risk factors for Moberg Pharma, including commercial risk, clinical and product development risk and regulatory risk. In addition, Moberg Pharma is dependent on distribution partners in markets outside of the US.